Human herpesvirus 8 and Kaposi's sarcoma

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• Kaposi's sarcoma (KS) is an angioproliferative lesion.
• Human herpesvirus type 8 (HHV8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), has been identified as the causative agent of KS.
• Previous reports suggested HHV8 is ubiquitous, but this is contested by serological data.

Purpose of the Study:

• To investigate the prevalence of HHV8.
• To clarify the role of HHV8 in different forms of KS.
• To understand the relationship between HHV8 and human immunodeficiency virus (HIV) in KS pathogenesis.

Main Methods:

• Polymerase chain reaction (PCR) for viral detection.
• Serological studies on blood donors and patients.
• Application of molecular probes in histological sections.
• Analysis of KSHV RNA molecules and viral cytokine mimics.

Main Results:

• HHV8 is essential for all clinical forms of KS and a specific diagnostic marker.
• Serological studies contradict PCR-based reports of HHV8 ubiquity.
• KSHV RNA and viral cytokine mimics provide insights into the viral lifecycle.
• The rise in classical KS in Nordic countries may be linked to KSHV spread.

Conclusions:

• HHV8 is the causative agent of Kaposi's sarcoma.
• The prevalence of HHV8 requires further investigation using serological surveys and molecular probes.
• HIV's role in AIDS-related KS is primarily as an immunodeficiency cause, not a direct cofactor for KS development.
• Understanding KSHV's latent-lytic cycle and cytokine interactions is crucial for KS research.